Targeting p300 HAT Activity as a Novel Anticancer Strategy

  • Starts: 2:00 pm on Wednesday, April 10, 2013
  • Ends: 3:20 pm on Wednesday, April 10, 2013
Rhoda M. Alani, M.D., Herbert Mescon Professor and Chair, Department of Dermatology, Boston University School of Medicine; Dermatologist-in-Chief, Boston Medical Center, will present her seminar "Targeting p300 HAT Activity as a Novel Anticancer Strategy."
Location:
R-115

Back to Calendar